Acrylic Acid

Acrylic Acid

SCHEMBL3955124

C=CC(=O)O.CCc1ccccc1NC(=O)O

nearest known ligand 0.61

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 5/20 0.52
HTT P42858 3/20 0.52
LMNA P02545 2/20 0.52
NPSR1 Q6W5P4 1/20 0.52
L3MBTL1 Q9Y468 1/20 0.52
ALDH1A1 P00352 3/20 0.50
POLB P06746 2/20 0.50
GAA P10253 2/20 0.50
HDAC3 O15379 1/20 0.50
HDAC4 P56524 1/20 0.50
HDAC1 Q13547 1/20 0.50
HDAC7 Q8WUI4 1/20 0.50
HDAC2 Q92769 1/20 0.50
HDAC10 Q969S8 1/20 0.50
HDAC11 Q96DB2 1/20 0.50
HDAC8 Q9BY41 1/20 0.50
HDAC6 Q9UBN7 1/20 0.50
HDAC9 Q9UKV0 1/20 0.50
HDAC5 Q9UQL6 1/20 0.50
KCNK3 O14649 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL948318 0.89 MAPT (0.59) MAPTHTTLMNANPSR1L3MBTL1
Hydrochloric Acid SCHEMBL22346017 0.87 MAPT (0.58) MAPTHTTLMNANPSR1L3MBTL1
SCHEMBL7178423 0.84 EGFR (0.52) MAPTHTTLMNANPSR1L3MBTL1
SCHEMBL9064516 0.81 ALDH1A1 (0.43) MAPTHTTLMNANPSR1L3MBTL1
SCHEMBL2022897 0.79 POLB (0.53) MAPTHTTLMNANPSR1L3MBTL1
SCHEMBL10950830 0.78 KDM4E (0.65) MAPTHTTLMNANPSR1L3MBTL1
SCHEMBL30764108 0.78 KDM4E (0.65) MAPTHTTLMNANPSR1L3MBTL1
SCHEMBL4933159 0.78 MAPT (0.51) MAPTHTTLMNANPSR1L3MBTL1
SCHEMBL9717979 0.77 HTT (0.72) MAPTHTTALDH1A1POLBGAA
SCHEMBL29580443 0.77 HTT (0.72) MAPTHTTALDH1A1POLBGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7498394-B2 (Meth)acrylic and (meth)acrylamide monomers, polymerizable compositions, and polymers obtained THE REGENTS OF THE UNIVERSITY OF COLORADO (US) 2009-03-03 US disclosed
US-20060252900-A1 (Meth)arcrylic and (meth)acrylamide monomers, polymerizable compositions, and polymers obtained REGENTS OF THE UNIVERSITY OF COLORADO, THE 2006-11-09 US disclosed
WO-2004077511-A2 (METH)ACRYLIC AND (METH)ACRYLAMIDE MONOMERS, POLYMERIZABLE COMPOSITIONS, AND POLYMERS OBTAINED THE REGENTS OF THE UNIVERSITY OF COLORADO (US) 2004-09-10 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060252900-A1 (Meth)arcrylic and (meth)acrylamide monomers, polymerizable compositions, and polymers obtained MMAB, MAT1A, MAT2A MAPT 641/4885HTT 45/4885LMNA 4478/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.